Giampiero Candeloro

624 total citations
33 papers, 333 citations indexed

About

Giampiero Candeloro is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Giampiero Candeloro has authored 33 papers receiving a total of 333 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 11 papers in Pulmonary and Respiratory Medicine and 8 papers in Surgery. Recurrent topics in Giampiero Candeloro's work include Cancer Immunotherapy and Biomarkers (8 papers), Breast Cancer Treatment Studies (7 papers) and Cancer Treatment and Pharmacology (6 papers). Giampiero Candeloro is often cited by papers focused on Cancer Immunotherapy and Biomarkers (8 papers), Breast Cancer Treatment Studies (7 papers) and Cancer Treatment and Pharmacology (6 papers). Giampiero Candeloro collaborates with scholars based in Italy, Guatemala and United States. Giampiero Candeloro's co-authors include Silvio Rea, F. Recchia, Alisia Cesta, Gaetano Saggio, Anna Di Blasio, Stefano Necozione, Antonio Nuzzo, Juan Piazze, G Carta and Marco Lombardo and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Giampiero Candeloro

32 papers receiving 321 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Giampiero Candeloro Italy 10 171 104 98 73 67 33 333
Alisia Cesta Italy 11 192 1.1× 104 1.0× 85 0.9× 60 0.8× 54 0.8× 20 339
JH Kim South Korea 7 95 0.6× 65 0.6× 33 0.3× 65 0.9× 63 0.9× 18 311
Atsuya Fujito Japan 8 68 0.4× 198 1.9× 105 1.1× 24 0.3× 98 1.5× 12 391
Masaya Uno Japan 10 72 0.4× 115 1.1× 28 0.3× 35 0.5× 70 1.0× 47 334
Géraldine Van Den Steen Belgium 8 140 0.8× 50 0.5× 58 0.6× 24 0.3× 127 1.9× 15 337
Rosemary Lord United Kingdom 11 182 1.1× 128 1.2× 13 0.1× 28 0.4× 119 1.8× 34 396
Florence Burtin France 8 116 0.7× 24 0.2× 23 0.2× 97 1.3× 45 0.7× 17 307
Jacek Jan Sznurkowski Poland 12 163 1.0× 97 0.9× 13 0.1× 107 1.5× 40 0.6× 38 415
H Serment France 6 107 0.6× 73 0.7× 62 0.6× 56 0.8× 47 0.7× 29 355

Countries citing papers authored by Giampiero Candeloro

Since Specialization
Citations

This map shows the geographic impact of Giampiero Candeloro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giampiero Candeloro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giampiero Candeloro more than expected).

Fields of papers citing papers by Giampiero Candeloro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giampiero Candeloro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giampiero Candeloro. The network helps show where Giampiero Candeloro may publish in the future.

Co-authorship network of co-authors of Giampiero Candeloro

This figure shows the co-authorship network connecting the top 25 collaborators of Giampiero Candeloro. A scholar is included among the top collaborators of Giampiero Candeloro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giampiero Candeloro. Giampiero Candeloro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Recchia, F., et al.. (2015). Adjuvant Ovarian Suppression, High-dose Chemotherapy and Immunotherapy for Premenopausal Patients with High-risk Breast Cancer.. PubMed. 35(12). 6847–53. 8 indexed citations
2.
Recchia, F., Giampiero Candeloro, Alisia Cesta, et al.. (2014). Anthracycline-based induction chemotherapy followed by concurrent cyclophosphamide, methotrexate and 5-fluorouracil and radiation therapy in surgically resected axillary node-positive breast cancer. Molecular and Clinical Oncology. 2(3). 473–478. 1 indexed citations
3.
Recchia, F., Giampiero Candeloro, Stefano Necozione, et al.. (2013). Vascular endothelial growth factor expression and T-regulatory cells in premenopausal breast cancer. Oncology Letters. 5(4). 1117–1122. 4 indexed citations
4.
Recchia, F., Giampiero Candeloro, Alisia Cesta, et al.. (2013). Abstract 480: Maintenance immunotherapy following carboplatin (CBDCA) - pemetrexed (PEM) chemotherapy in advanced adenocarcinoma (ADK) of the lung: A phase II study.. Cancer Research. 73(8_Supplement). 480–480. 1 indexed citations
5.
Recchia, F., Giampiero Candeloro, Giovambattista Desideri, Stefano Necozione, & Stephen Rea. (2011). Estrogen and vascular endothelial growth factor (VEGF): Their role in breast cancer (BC) carcinogenesis and disease progression in premenopause.. Journal of Clinical Oncology. 29(15_suppl). 540–540. 1 indexed citations
6.
Recchia, F., Giampiero Candeloro, Juan Piazze, et al.. (2010). Liposomal pegylated doxorubicin and oxaliplatin as salvage chemotherapy in patients with metastatic gastric cancer treated earlier. Anti-Cancer Drugs. 21(5). 559–564. 8 indexed citations
7.
8.
Recchia, F., Gigliola Sica, Giampiero Candeloro, et al.. (2009). Chemoradioimmunotherapy in Locally Advanced Pancreatic and Biliary Tree Adenocarcinoma. Pancreas. 38(6). e163–e168. 12 indexed citations
9.
Recchia, F., et al.. (2009). Immunotherapy in patients with less than complete response to chemotherapy.. PubMed. 29(2). 567–72. 6 indexed citations
10.
Recchia, F., et al.. (2009). Maintenance immunotherapy in recurrent ovarian cancer: Long term follow-up of a phase II study. Gynecologic Oncology. 116(2). 202–207. 22 indexed citations
11.
Recchia, F., Giampiero Candeloro, Stefano Necozione, et al.. (2008). Maintenance immunotherapy (MI) in recurrent or metastatic squamous cell carcinoma of the head and neck (RMHN). Cancer Research. 68. 2153–2153. 1 indexed citations
12.
Recchia, F., Giampiero Candeloro, Mario Di Staso, et al.. (2008). Maintenance Immunotherapy in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck. Journal of Immunotherapy. 31(4). 413–419. 7 indexed citations
13.
Recchia, F., et al.. (2008). Alternating XELFOX and XELFIRI in Patients With Metastatic Colorectal Cancer. American Journal of Clinical Oncology. 31(4). 323–328. 5 indexed citations
14.
Recchia, F., Gaetano Saggio, Anna Di Blasio, et al.. (2007). A multicenter phase II study of pegylated liposomal doxorubicin and oxaliplatin in recurrent ovarian cancer. Gynecologic Oncology. 106(1). 164–169. 19 indexed citations
15.
Recchia, F., Gaetano Saggio, Anna Di Blasio, et al.. (2007). Multicenter Phase II Study of Chemo-immunotherapy in the Treatment of Metastatic Renal Cell Carcinoma. Journal of Immunotherapy. 30(4). 448–454. 10 indexed citations
16.
Recchia, F., Gaetano Saggio, Giampiero Candeloro, et al.. (2007). Chemoimmunotherapy in the treatment of metastatic gastric cancer. Anti-Cancer Drugs. 18(5). 597–604. 6 indexed citations
17.
Recchia, F., Gaetano Saggio, Alisia Cesta, et al.. (2006). Dose-finding study of docetaxel added to ifosfamide and cisplatin followed by concomitant capecitabine and radiotherapy in the treatment of locally advanced squamous cell carcinoma of the head and neck.. PubMed. 26(3B). 2317–24. 3 indexed citations
18.
19.
Recchia, F., Gaetano Saggio, Alisia Cesta, Giampiero Candeloro, & Silvio Rea. (2005). Paclitaxel plus gemcitabine in advanced non-small cell lung cancer patients with low performance status.. PubMed. 25(1B). 409–14. 5 indexed citations
20.
Recchia, F., Gaetano Saggio, Antonio Nuzzo, et al.. (2005). Multicenter Phase 2 Study of Interleukin-2 and 13-Cis Retinoic Acid as Maintenance Therapy in Advanced Non-Small-Cell Lung Cancer. Journal of Immunotherapy. 29(1). 87–94. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alisia Cesta Breakdown of academic impact, for papers by JH Kim Breakdown of academic impact, for papers by Atsuya Fujito Breakdown of academic impact, for papers by Masaya Uno Breakdown of academic impact, for papers by Géraldine Van Den Steen Breakdown of academic impact, for papers by Rosemary Lord Breakdown of academic impact, for papers by Florence Burtin Breakdown of academic impact, for papers by Jacek Jan Sznurkowski Breakdown of academic impact, for papers by H Serment
Rankless by CCL
2026